Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Fuji
Boehringer Ingelheim
Baxter
Moodys
Citi
Mallinckrodt
UBS
QuintilesIMS
Chubb

Generated: February 19, 2018

DrugPatentWatch Database Preview

HEPARIN LOCK FLUSH Drug Profile

« Back to Dashboard

When do Heparin Lock Flush patents expire, and when can generic versions of Heparin Lock Flush launch?

Heparin Lock Flush is a drug marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, and Solopak. and is included in seventeen NDAs.

The generic ingredient in HEPARIN LOCK FLUSH is heparin sodium. There are seventy-seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for HEPARIN LOCK FLUSH
Drug patent expirations by year for HEPARIN LOCK FLUSH

US Patents and Regulatory Information for HEPARIN LOCK FLUSH

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira HEPARIN LOCK FLUSH heparin sodium INJECTABLE;INJECTION 005264-010 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Solopak HEPARIN LOCK FLUSH heparin sodium INJECTABLE;INJECTION 088459-001 Jul 26, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Smith And Nephew HEPARIN LOCK FLUSH heparin sodium INJECTABLE;INJECTION 087904-001 Apr 20, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold HEPARIN LOCK FLUSH heparin sodium INJECTABLE;INJECTION 089063-001 Oct 9, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Smith And Nephew HEPARIN LOCK FLUSH heparin sodium INJECTABLE;INJECTION 087959-001 Apr 20, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Smith And Nephew HEPARIN LOCK FLUSH heparin sodium INJECTABLE;INJECTION 087958-001 Apr 20, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Solopak HEPARIN LOCK FLUSH heparin sodium INJECTABLE;INJECTION 088457-001 Oct 25, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Smith And Nephew HEPARIN LOCK FLUSH heparin sodium INJECTABLE;INJECTION 088581-001 Oct 25, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Intl Medication HEPARIN LOCK FLUSH heparin sodium INJECTABLE;INJECTION 086357-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Intl Medication HEPARIN LOCK FLUSH heparin sodium INJECTABLE;INJECTION 086357-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cipla
Federal Trade Commission
Covington
Cerilliant
Chubb
Daiichi Sankyo
McKinsey
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot